All tissues undergo continuous reconditioning via the complex orchestration of changes in tissue protein synthesis and breakdown rates. Skeletal muscle tissue has been well studied in this regard, and has been shown to turnover at a rate of 1-2% per day in vivo in humans. Few data are available on protein synthesis rates of other tissues. Because of obvious limitations with regard to brain tissue sampling no study has ever measured brain protein synthesis rates in vivo in humans. Here, we applied stable isotope methodology to directly assess protein synthesis rates in neocortex and hippocampus tissue of six patients undergoing temporal lobectomy for drug-resistant temporal lobe epilepsy (Clinical trial registration: NTR5147). Protein synthesis rates of neocortex and hippocampus tissue averaged 0.17 AE 0.01 and 0.13 AE 0.01%/h, respectively. Brain tissue protein synthesis rates were 3-4-fold higher than skeletal muscle tissue protein synthesis rates (0.05 AE 0.01%/h; P 5 0.001). In conclusion, the protein turnover rate of the human brain is much higher than previously assumed.
Introduction
Plasticity of biological tissues allows organic material to adapt to various conditional changes. One aspect of plasticity is the capacity of tissues to remodel via the complex orchestration of changes in tissue protein synthesis and breakdown rates. Skeletal muscle tissue has been shown to display a high level of tissue plasticity with protein turnover rates ranging between 1-2% per day in vivo in humans (Waterlow, 2006) . Data on protein synthesis rates of other organs are scarce, with most work being performed in animal models (Fern and Garlick, 1974; Preedy and Garlick, 1985; Preedy et al., 1988; Cherel et al., 1991; Bark et al., 1998; Johnson et al., 1999) .
An organ that has historically been considered to possess a limited degree of tissue plasticity, particularly after a certain age, is the human brain. William James (1890) is generally considered the first to acknowledge the plasticity of the human brain. He proposed that 'the phenomena of habit in living beings are due to the plasticity of the organic materials of which their bodies are composed' (James, 1890) . With this proposition he not only suggested that plasticity involves more than the outward shape or inner contents of a tissue, but he also gave rise to a different understanding of the influence of neural matter plasticity on cognition and behaviour. Though the term neuroplasticity is often applied in neuroscience to express synaptic or non-synaptic plasticity, there is little information on the actual capacity of brain tissue to recondition. More recent work on human brain tissue plasticity has applied MRI to show increases in grey matter in the posterior and lateral parietal cortex in medical students learning for their medical examination (Draganski et al., 2006) . Others have reported elevated levels of grey matter in the hippocampus of people with a high dependence on navigational skills (Maguire et al., 2006) . This remodelling of neocortical and hippocampal brain tissue may be reflective of high brain tissue protein turnover rates in humans.
Because of the obvious limitations with regard to brain tissue sampling, no study has ever attempted to assess brain tissue protein turnover rates in vivo in humans. Previous studies investigating protein turnover in human brain tissue have presented estimates of protein synthesis rates based on atmospheric tracer incorporation in cadavers (Libby et al., 1964) or on labelled amino acid PET (Hawkins et al., 1989; Sundaram et al., 2006) . Direct quantification of in vivo tissue protein synthesis rates requires continuous intravenous stable isotope labelled amino acid infusion with subsequent tissue sampling to directly assess amino acid tracer incorporation into (brain) tissue protein (Wolfe, 1984; Rennie et al., 1994; Wagenmakers, 1999) . To date, such stable isotope incorporation studies in vivo in humans have mainly focused on protein synthesis in skeletal muscle because of the relative ease of muscle tissue sampling using a Bergströ m needle (Bergstrom, 1975) . However, no study has ever tried to use this methodology to allow such a direct and comprehensive assessment of tissue protein synthesis rates in vivo in the human brain. Here we applied contemporary stable isotope methodology to directly measure neocortical and hippocampal tissue protein synthesis rates in vivo in humans.
Materials and methods

Subjects
Six otherwise healthy male (n = 2) and female (n = 4) adults (age: 47 AE 6 years; body weight: 81.3 AE 7.8 kg), scheduled to undergo temporal lobe resection surgery for drug-resistant temporal lobe epilepsy (TLE), were recruited to participate in the present study. Subjects had no history of participating in any stable isotope infusion study before this experiment. All subjects were informed about the nature and possible risks of the experimental procedures, before their written informed consent was obtained. The study was approved by the Medical Ethical Committee of Zuyderland Medical Centre, Heerlen, The Netherlands, and conformed to the principles outlined in the Declaration of Helsinki for use of human subjects and tissue (Clinical trial registration: NTR5147).
Experimental design
The experimental protocol is outlined in Fig. 1 . Each subject was diagnosed with drug-resistant temporal lobe epilepsy, and therefore underwent epilepsy surgery at the Department of Neurosurgery at Maastricht University Medical Centre + , The Netherlands. Patients underwent anterior temporal lobectomy (n = 6), which was combined with an amygdalohippocampectomy in five cases using neuronavigational guidance. The procedure involves resection of 4-6 cm of the anterior temporal lobe, depending on the side for language dominance. This enables access to and resection of mesial structures including the amygdala and the hippocampus. Before and during surgery patients were subjected to primed continuous intravenous infusions with L-[ring- 13 C 6 ]-phenylalanine and
H 2 ]-tyrosine. Arterial blood and tissue samples were collected throughout the surgical procedure to assess neocortical, hippocampal, temporal muscle, as well as vastus lateralis muscle fractional tissue protein synthesis rates (%/h). Because of the explorative and descriptive nature of the experimental design, no blinding or randomization was performed.
Infusion protocol
All patients were fasted for at least 6 h prior to surgery. Two and a half hours before surgery a Teflon Õ catheter was inserted into an antecubital vein for stable isotope infusion. After taking a baseline blood sample, the serum phenylalanine and tyrosine pools were primed with a single dose of L-[ring-13 C 6 ]-phenylalanine (2 mmol/kg) and L-[3,5-2 H 2 ]-tyrosine (0.824 mmol/kg), after which continuous intravenous L-[ring-13 C 6 ]-phenylalanine (0.05 mmol/kg/min) and L-[3,5-2 H 2 ]-tyrosine (0.018 mmol/kg/min) infusions were initiated (t = À150 min).
To determine basal tissue protein synthesis, tissue samples of the neocortex, hippocampus, temporalis muscle, and vastus lateralis muscle were obtained throughout the surgical procedure. All tissue samples were collected through surgical excision, except for the vastus lateralis muscle, which was collected from the middle region of the vastus lateralis, $15 cm above the patella and 3 cm below entry through the fascia, using the percutaneous needle biopsy technique (Bergstrom, 1975) . All samples were freed from any visible blood, immediately frozen in liquid nitrogen, and stored at À80 C until subsequent analysis. In addition, arterial blood samples were collected at frequent intervals to determine L-[ring-13 C 6 ]-phenylalanine enrichment. Blood samples were collected in serum tubes and centrifuged at 3500g for 15 min at 20
C to obtain serum. Aliquots of serum were frozen in liquid nitrogen and stored at À80 C.
Serum analyses
Serum amino acid concentrations and enrichments were determined by gas chromatography/mass spectrometry (GC-MS; Agilent 7890A GC/5975C). Specifically, internal standards of L-[ring-13 C 6 ]-phenylalanine were added to the samples.
The serum was deproteinized on ice with dry 5-sulfosalicylic acid. Free amino acids were purified using cation exchange AG 50W-X8 resin [mesh size: 100-200, ionic form: hydrogen (Bio-Rad Laboratories)] columns. The free amino acids were converted to their tert-butyl dimethylsilyl (TBDMS) derivative before analysis by GC-MS. The amino acid concentrations were determined using electron impact ionization by monitoring ions at mass/charge (m/z) 336 and 346 for unlabelled and L-[ring-13 C 6 ]-phenylalanine, respectively. The serum phenylalanine 13 C enrichments were determined using selective ion monitoring at m/z 336 and 342 for unlabelled and labelled phenylalanine, respectively. Standard regression curves were applied from a series of known standard enrichment values against the measured values to assess the linearity of the mass spectrometer and to account for any isotope fractionation that may have occurred during the analysis. Phenylalanine enrichments were corrected for the presence of 13 C isotopes.
Tissue analyses
All tissues were freeze-dried, weighed and crushed. Subsequently, samples were homogenized in ice-cold 2% perchloric acid (PCA) using ultrasonic disintegration (Soniprep; MSE). Samples were incubated on ice for 10 min. Following centrifugation, the supernatant was collected for determination of L-[ring-13 C 6 ]-Phenylalanine enrichments in the tissue free amino acid pool using GC-MS analysis. The tissue protein pellet was washed three times with 1.5 ml of ice-cold 2% PCA and hydrolysed in 3 ml of 6 M HCl overnight at 120 C. The free amino acids were then dissolved in 50% acetic acid solution and passed over cation exchange AG 50W-X8 resin [mesh size: 100-200, ionic form: hydrogen . The derivatives were then measured by GC-combustion-isotope ratio MS (MAT 253; Finnigan) using an Agilent J&W DB-5ms GC-column (Agilent Technologies), and monitoring of ion masses 44 and 45. By establishing the relation between the enrichment of a series of L-[ring-13 C 6 ]-phenylalanine standards of variable enrichments and the enrichments of the N(O,S)-ethoxycarbonyl ethyl esters of these standards, the tissue protein-bound enrichment of phenylalanine was determined. Standard regression curves were applied to assess the linearity of the mass spectrometer and to control for the loss of tracer.
Protein identification
Tissue samples were homogenized in 50 mM ammonium bicarbonate and 5 M urea buffer, freeze-dried in three cycles, vortexed for 1 min and centrifuged at 20 000g for 30 min at 10 C. The supernatant was collected and stored at À80 C until further analysis. Protein concentrations were determined with the Protein Assay Kit from Bio-Rad. Subsequently, a total of 75 mg protein in 50 ml 50 mM ammonium bicarbonate with 5 M urea was used for further analysis. Five microlitres of dithiothreitol (DTT) solution (20 mM final) was added and incubated at room temperature for 45 min. Proteins were alkylated by adding 6 ml of indole-3-acetic acid (IAA) solution (40 mM final) and incubated at room temperature for 45 min in darkness. Alkylation was stopped by adding 10 ml DTT solution Figure 1 Schematic representation of the study outline and stable isotope infusion protocol. GC-MS = gas chromatography-mass spectrometry; GC-IRMS = gas chromatography isotope ratio mass spectrometry. T = 0 represents the start of surgery.
(to consume any unreacted IAA) and incubation at room temperature for 45 min. Subsequently, 3 mg trypsin/lysC was added to the protein and incubated at 37 C for 2 h. Two hundred microlitres of 50 mM ammonium bicarbonate was added to dilute the urea concentration and the solution was further incubated at 37 C for 18 h. The digestion mixture was centrifuged at 2500g for 5 min and the supernatant was collected. The digestion mixture was 4-fold diluted for the use of liquid chromatography/mass spectrometry (LC-MS/MS) analysis. LC-MS/MS was performed using a nanoflow HPLC instrument (Dionex ultimate 3000) coupled on-line to a Q Exactive (Thermo Scientific) with a nano-electrospray Flex ion source (Proxeon). The digest/peptide mixture was loaded onto a C18-reversed phase column (Thermo Scientific Acclaim PepMap C18 column, 75 mm inner diameter Â 15 cm, 2 mm particle size). Peptides were separated with a 90 min linear gradient of 4-45% buffer (80% acetonitrile and 0.08% formic acid) at a flow rate of 300 nl/min. Proteins were identified using Proteome Discoverer v2.1 Sequest HT search engine (Thermo Scientific). The false discovery rate (FDR) was set to 0.01 for proteins and peptides.
Calculations
Tissue protein fractional synthesis rates (FSRs) were calculated using the standard precursor-product equation:
E p1 and E p2 are the protein-bound enrichments measured in the tissue samples collected during surgery and serum proteins (at t = 0 h), respectively. E precursor is the average serum free or tissue free L-[ring-13 C 6 ]-phenylalanine enrichment to estimate the upper (i.e. tissue free) and lower (i.e. serum free enrichment) limits of the true tissue protein fractional synthesis rate (Rennie et al., 1994) , and t indicates the tracer incorporation time.
Statistical analysis
All data are expressed as means AE standard error of the mean (SEM). A paired t-test was used to compare intracellular free L-[ring-13 C 6 ]-phenylalanine enrichments of the different tissues with muscle free L-[ring-13 C 6 ]-phenylalanine enrichments. For all analyses, statistical significance was set at P 5 0.05. All calculations were performed using SPSS (version 23.0, IBM Corp., Armonk, NY, USA).
Results
Serum enrichments
Following the onset of intravenous L-[ring-13 C 6 ]-phenylalanine administration a steady state in arterial amino acid tracer enrichment was obtained prior to surgery and maintained throughout the surgical procedures (Fig. 2) . Throughout the surgical intervention, serum L-[ring-
13
C 6 ]-phenylalanine enrichments averaged 8.12 AE 0.70 mole per cent excess (MPE).
Tissue protein enrichments
Skeletal muscle tissue biopsies were obtained from the vastus lateralis muscle at a time point close to brain tissue sampling to provide reference values. Vastus lateralis L-[ring-
13
C 6 ]-phenylalanine enrichments averaged 0.025 AE 0.006 MPE. In addition, similar enrichment levels were observed in temporalis muscle tissue (0.021 AE 0.002 MPE; P = 0.324). However, L-[ring-
C 6 ]-phenylalanine enrichment levels in hippocampal and neocortical tissue (0.066 AE 0.008 and 0.067 AE 0.005 MPE, respectively) were significantly higher compared to vastus lateralis muscle tissue (P 5 0.01; Supplementary Fig. 1 ).
Tissue protein synthesis rates
Calculating tissue-specific fractional synthetic rates based on serum and tissue protein bound L-[ring-
13
C 6 ]-phenylalanine enrichments revealed similar results. Skeletal muscle fractional synthetic rates averaged 0.05 AE 0.01 %/h for vastus lateralis muscle and 0.04 AE 0.01 %/h for temporalis muscle (P = 0.442). Fractional synthetic rates of hippocampal and neocortical brain tissue (0.13 AE 0.01 and 0.17 AE 0.01 %/h, respectively) were significantly higher compared to vastus lateralis muscle tissue (P 5 0.001; Fig. 3) . Moreover, neocortical tissue fractional synthetic rates were significantly higher when compared to hippocampal tissue fractional synthetic rates (P 5 0.05; Fig. 3 ).
Protein identifications
Identification of proteins present in the brain tissue samples revealed 1192 different proteins. A complete list of all identified proteins and their corresponding (estimated) abundances is provided in Supplementary Table 1. In addition, an overview of all identified proteins classified by protein class are presented in Fig. 4 
Discussion
This is the first study to measure high brain tissue protein synthesis rates in vivo in humans. Using contemporary stable isotope methodology, we show that protein synthesis rates of human brain tissue are 3-4-fold higher when compared to skeletal muscle tissue protein synthesis rates.
Skeletal muscle protein synthesis rates averaged 0.05 AE 0.01 %/h in our patients (Fig. 3) . These rates do not differ from muscle protein synthesis rates assessed previously in an overnight fasted state in subjects studied in our lab (Burd et al., 2012; Hursel et al., 2015; Kouw et al., 2015; Wall et al., 2015; Gorissen et al., 2016 Gorissen et al., , 2017 Kramer et al., 2016) as well as in other laboratories (Volpi et al., 2001; Waterlow, 2006; Yang et al., 2012a, b) . Following craniotomy we also sampled tissue from the temporalis muscle. Interestingly, temporalis muscle protein synthesis rates did not differ from the vastus lateralis muscle (0.04 AE 0.01 versus 0.05 AE 0.01 %/h, respectively; Fig. 3 ). There are only few studies that have measured muscle protein synthesis rates in muscle tissue other than vastus lateralis (Carroll et al., 2005; Mittendorfer et al., 2005; West et al., 2009) . Despite the obvious differences in muscle structure and function, there seem to be little differences in post-absorptive skeletal muscle protein synthesis rates between the different muscle groups. The latter is of course highly relevant for future work that requires reference values for tissue protein synthesis rates when there is no possibility of also sampling vastus lateralis tissue. In accordance with numerous observations, skeletal muscle tissue turns over at a rate of 1-2% per day (Waterlow, 2006) , implying full renewal of muscle tissue protein over a 2-3-month period. This high rate of skeletal muscle tissue protein turnover is well appreciated as it allows skeletal muscle tissue to adapt to changes in habitual use. The latter is evident with muscle hypertrophy observed following resistance type exercise training (Chesley et al., 1992; Phillips et al., 1997; Cermak et al., 2012) or muscle tissue atrophy developing during periods of disuse (Deitrick, 1948; Ingemann-Hansen and Halkjaer-Kristensen, 1980; Gibson et al., 1987) . Of course, muscle (re)conditioning generally includes inner renewal or remodelling without measurable changes in tissue mass.
The human brain has historically been considered to possess quite a limited degree of plasticity, particularly after a certain age. Nonetheless there are several reports of structural changes in neocortical and hippocampal brain tissue upon efforts to develop cognitive skills (Draganski et al., 2006; Maguire et al., 2006) . Whether this capacity for brain tissue remodelling is facilitated by high brain tissue protein turnover rates remains to be established. Because of the limitations with regard to brain tissue sampling no study has ever attempted to measure brain tissue protein synthesis rates in vivo in humans. Since the second half of the 19th century, epilepsy surgery has been performed to relieve seizures in patients with drug-resistant epilepsy. Throughout the 20th century this developed into highly specialized microscopic navigation-guided surgery to resect lesional and nonlesional epileptogenic areas in the brain (Schijns et al., 2015) . Few epilepsy patients undergo an anterior temporal lobectomy frequently combined with an amygdalohippocampectomy, i.e. removal of the anterior side of the temporal lobe combined with removal of the amygdala and hippocampus. This provided us with an opportunity to collect neocortical and hippocampal human brain tissue throughout the surgical procedure in these patients.
Measuring neocortical and hippocampal tissue protein synthesis revealed high tissue protein synthesis rates, averaging 0.17 AE 0.01 and 0.13 AE 0.01 %/h, respectively. Neocortex tissue protein synthesis rates were significantly higher when compared to hippocampal tissue protein turnover (P 5 0.05; Fig. 3 ). Such high tissue protein turnover rates are remarkable, especially when compared with the 3-4-fold lower skeletal muscle protein synthesis rates. This high brain tissue protein turnover rate may reflect the level of tissue plasticity of the human brain and, as such, may open up many new perspectives.
Obviously, our assessment of brain tissue protein synthesis rates represents the integrated synthesis rates of all available proteins in the brain tissue that was sampled. To obtain some degree of insight into the plethora of proteins present in brain tissue, we applied LC-MS/MS (Fig. 1) sample. In addition, this table includes the results of a semiquantitative analysis on the abundances of these proteins.
To summarize the most important data from this analysis, Fig. 4 and C 6 ]-phenylalanine labelling observed within $6-8 h of tracer infusion is too low to enable reliable detection of individual protein-specific enrichments when using LC-MS/MS. Nevertheless, we believe that limitations in both the sensitivity of the equipment and the level of isotope labelling in vivo in humans may soon be resolved.
Where skeletal muscle tissue has been shown to turnover at a rate of 1-2% per day, here we show that brain tissue turns over much faster at a rate of 3-4% per day. This would imply complete renewal of brain tissue proteins well within 4-5 weeks. From a physiological viewpoint this is astounding, as it provides us with a much greater framework for the capacity of brain tissue to recondition. Moreover, from a philosophical perspective these observations are even more surprising. If rapid protein turnover of brain tissue implies that all organic material is renewed, then all data internalized in that tissue are also prone to renewal. These findings spark (even) more debate on the interpretation and (long-term) storage of data in neural matter, the capacity of humans to consciously or unconsciously process data, and the (organic) basis of our own personality and ego. All of this becomes quite remarkable in light of such rapid protein turnover rates of the human brain. Though these high brain tissue protein synthesis rates suggest a certain degree of brain tissue plasticity, a direct link between brain tissue protein synthesis and brain tissue plasticity remains to be established.
In conclusion, in vivo mixed protein synthesis rates of the human brain range between 3 and 4% per day, presenting a remarkably high tissue protein turnover rate. This high brain tissue protein turnover rate underlines the need to unravel the physiological mechanisms underlying brain tissue plasticity and their impact on the adaptive processes occurring in brain tissue. Insight into the dynamics of brain tissue protein turnover will allow a more thorough understanding of the structural and cognitive changes that can occur in the human brain in both health and disease.
